Gulf Pharmaceutical Industries PSC – Strategy, SWOT and Corporate Finance Report
- Pages: 46
- Published: June 2018
- Report Code: MLPH82290FSA
Gulf Pharmaceutical Industries PSC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Gulf Pharmaceutical Industries PSC (Julphar) is a pharmaceutical company that manufactures and distributes medicines in the Middle East and North Africa (MENA) region. The company's product portfolio consists of antibiotics, antiseptics, wound care and biotechnology, women care, adult primary care, pediatric primary care, cardiopulmonary care, gastro care and pain management and consumer care products. The company has manufacturing facilities in Ethiopia, Bangladesh and Saudi Arabia. Julphar has offices in Asia, Middle East and Africa and is headquartered in Digdaga, Ras Al Khaimah, the UAE.
Scope
Detailed information on Gulf Pharmaceutical Industries PSC required for business and competitor intelligence needs
A study of the major internal and external factors affecting Gulf Pharmaceutical Industries PSC in the form of a SWOT analysis
An in-depth view of the business model of Gulf Pharmaceutical Industries PSC including a breakdown and examination of key business segments
News about Gulf Pharmaceutical Industries PSC, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Gulf Pharmaceutical Industries PSC and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Gulf Pharmaceutical Industries PSC as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Gulf Pharmaceutical Industries PSCs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Yiaco Medical Co
Neopharma LLC
Globalpharma Co LLC
Elis Pharmaceuticals Ltd
Barakat Pharmaceutical Industries
Aburaihan Pharmaceutical Company
Abdi Ibrahim Ilac Sanayi ve Ticaret AS
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple report purchases.